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Abstract— The aim of the present research is to study the
magnetoencephalogram (MEG) background activity in patients
with Alzheimer’s disease (AD) using the Lempel-Ziv (LZ)
complexity. We recorded the MEG with a 148-channel whole-
head magnetometer (MAGNES 2500 WH, 4D Neuroimaging)
in 10 patients with probable AD and 10 age-matched control
subjects, during five minutes. Artefact-free epochs were selected
for the non-linear analysis. In all MEG channels, the AD
patients had lower complexity than control subjects. In 77 of
them the differences were statistically significant (p < 0.01).
These preliminary results suggest that cognitive dysfunction in
AD is associated with a decreased complexity in certain regions
of the brain.
I. INTRODUCTION
Alzheimer’s disease (AD) is one of the most frequent
disorders among the elderly population [1], [2] and it is con-
sidered to be the main cause of dementia in western countries
[3]. This degenerative neurological disease is characterized
by neuronal loss and the appearance of neuritic plaques
containing amyloid-β-peptide and neurofibrillary tangles [4],
[5]. The differential diagnosis with other types of dementia
includes Mini-Mental Status Examination (MMSE) of Fol-
stein [6], Stroop test, computerized tomography and magnetic
resonance imaging, although a definitive diagnosis is only
possible by necropsy.
The exact nature of the neurophysiological processes un-
derlying cognitive dysfunction in AD is still incompletely
understood [7]. There are several studies of the electroen-
cephalogram (EEG) and magnetoencephalogram (MEG) in
AD patients with non-linear methods. The most widely used
method is the correlation dimension (D2) [8], [9]. Never-
theless, there are several drawbacks in using this measure
for estimating the non-linear dynamic complexity. First, the
algorithm requires the data series to be stationary [10], which
cannot be achieved for physiological data. In addition, it
is necessary long time series to obtain meaningful results
[11]. Moreover, the reconstruction of the attractor in the
phase space is computationally very expensive. In spite of
its shortcomings, recently, D2 was computed and compared
with another measure of neural complexity (CN ) in AD
patients’ MEGs [12]. Other methods also have been used.
For instance, Stam et al. [7] detected that the mean level
of EEG synchronization was lower in AD patients in the
upper alpha (10-13 Hz) and beta (13-30 Hz) bands, and that
the spontaneous fluctuations of synchronization diminished
in AD patients in the lower alpha (8-10 Hz) and beta (13-30
Hz) bands. Other studies found that the local cross-mutual
information [13] and the Global Field Synchronization [14]
can distinguish between control subjects and AD patients.
The LZ complexity [15] is a nonparametric measure of
complexity in a one-dimensional signal related to the number
of distinct substrings and the rate of their recurrence. Huang
et al. [16] applied this method to characterize the functional
changes of the brain during isoflurane anaesthesia, extracting
the complexity from mutual information time series of EEGs.
Moreover, preliminary evidence suggests that, applied to
EEGs, LZ complexity is very sensitive to the extent of focal
ischemic cerebral injury, being able to distinguish ischemic
and normal region [17]. It has been applied to study the brain
function [18], brain information transmission [19] and to
detect ventricular tachycardia and fibrillation [20]. It can also
be used for quantifying the regularity at epochs of epileptic
seizures time-series data [21], and the relationship between
brain activity patterns and depth of anesthesia [22], [23].
In the present study, we have examined the MEG back-
ground activity in AD patients with the LZ complexity. The
purpose of this research is to test the hypothesis that the LZ
complexity measure applied to MEG data is lower in AD
patients compared to control subjects.
II. METHODS AND MATERIALS
A. Subjects
Ten patients (age = 66.3 ± 7.1 years, mean ± standard
deviation SD) fulfilling the criteria of probable AD and ten
control subjects (mean age, 65.8 ± 5.9 SD years) participated
in this study. Participants were recruited from the Asociacio´n
de Familiares de Enfermos de Alzheimer (AFAL). All pa-
tients with AD were diagnosed using criteria of the National
Institute of Communicative Disorders and Stroke and the AD
and Related Disorders Association (NINCDS-ADRDA) [24].
The mean MMSE score for the patients was 15.5 ± 4.1
(Mean ± SD). Two of them had a MMSE score of less than
12 points, indicating a severe degree of dementia. None of
the patients used any kind of medication that could have an
influence on the MEG. For the control subjects the MMSE
score was 29.4 ± 1.0 (Mean ± SD). The main characteristics
of all subjects are summarized in table I.
The local ethics committee approved the study. All control
subjects and all caregivers of the demented patients gave their
informed consent for the participation in the current study.
TABLE I
SOCIODEMOGRAPHIC DATA OF CONTROLS SUBJECTS AND PATIENTS
WITH ALZHEIMER DISEASE
AD patients Control subjects
Identification Age MMSE Identification Age MMSE
Alz-1 69 24 Con-1 68 30
Alz-2 71 15 Con-2 61 29
Alz-3 67 12 Con-3 70 30
Alz-4 56 14 Con-4 64 30
Alz-5 79 9 Con-5 60 30
Alz-6 64 15 Con-6 63 30
Alz-7 59 20 Con-7 73 29
Alz-8 60 16 Con-8 69 29
Alz-9 72 15 Con-9 56 27
Alz-10 71 15 Con-10 74 30
Mean 66.3 15.5 Mean 65.8 29.4
± SD ± 7.1 ± 4.1 ± SD ± 5.9 ± 1.0
B. MEG recording
MEGs were recorded using a 148-channel whole-head
magnetometer (MAGNES 2500 WH, 4D Neuroimaging) in
a magnetically shielded room. While lying comfortably on a
patient bed, subjects were asked to stay awake and to avoid
head and eye movements. With the subjects in a relaxed state
and eyes closed, 5 minutes of recording (sampling frequency
of 678.17 Hz) were acquired. These recordings were down-
sampled to 169.549 Hz (50863 data points).
All data were digitally filtered using a band-pass filter with
cut-off frequencies at 0.4 Hz and at 70 Hz in order to reject
artifacts. Low-frequency artifacts were typically due to eye
movements and high-frequency ones were typically due to
muscle activity. A second-order notch filter at 50 Hz was
used to remove the line frequency.
Artifact-free epochs of 3392 samples (20 seconds) were
selected from the MEG signal. The epochs were copied
as ASCII files to a personal computer for further off-line
analysis.
C. Lempel-Ziv complexity
The Lempel-Ziv (LZ) complexity for sequences of finite
length was suggested by Lempel and Ziv [15]. It is a nonpara-
metric, simple-to-calculate measure of complexity in a one-
dimensional signal that does not require long data segments
to compute [20]. LZ complexity is related to the number
of distinct substrings and the rate of their recurrence along
the given sequence [21], with larger values corresponding to
more complexity in the data.
LZ complexity analysis is based on a coarse-graining of the
measurements, so before calculating the complexity measure
c(n), the signal must be transformed into a finite symbol
sequence.
The simplest way is selected to convert time series values
[x(i), i = 1, 2, . . . , N ] into a sequence of characters (zero
and one). The median value is estimated as a threshold Td,
as partitioning about the median is robust to outliers [25]. By
comparison with the threshold, the signal data are converted
into a 0-1 sequence P = s(1), s(2), . . . , s(n), with s(i)
defined by [22]:
s(i) =
{
0 if x(i) < Td
1 if x(i) ≥ Td
(1)
The sequence P is scanned from left to right increasing
the complexity counter c(n) by one unit every time a new
subsequence of consecutive characters is encountered. The
complexity measure can be estimated using the following
algorithm [20] [22] [23]:
1) Let S and Q denote two subsequences of P and SQ
be the concatenation of S and Q, while sequence SQpi
is derived from SQ after its last character is deleted
(pi means the operation to delete the last character in
the sequence). Let v(SQpi) denote the vocabulary of
all different subsequences of SQpi. At the beginning,
c(n) = 1, S = s(1), Q = s(2), therefore, SQpi = s(1).
2) In general, S = s(1), s(2), . . . , s(r), Q = s(r+1), then
SQpi = s(1), s(2), . . . , s(r); if Q belongs to v(SQpi),
then Q is a subsequence of SQpi, not a new sequence.
3) Renew Q to be s(r+1), s(r+2) and judge if Q belongs
to v(SQpi) or not.
4) Repeat the previous steps until Q does not belong to
v(SQpi). Now Q = s(r+1), s(r+2), . . . , s(r+i) is not
a subsequence of SQpi = s(1), s(2), . . . , s(r + i− 1),
so increase c(n) by one.
5) Thereafter, S is renewed to be S =
s(1), s(2), . . . , s(r + i), and Q = s(r + i+ 1).
These procedures have to be repeated until Q is the last
character. At this time the number of different subsequences
in P –the measure of complexity– is c(n).
In order to obtain a complexity measure which is indepen-
dent of the sequence length, c(n) should be normalized. If
the length of the sequence is n and the number of different
symbols in the symbol set is α, it has been proved [15] that
the upper bound of c(n) is given by:
c(n) <
n
(1− εn) logα(n)
(2)
where εn is a small quantity and εn → 0 (n → ∞). In
general, n/ logα(n) is the upper bound of c(n), where the
base of the logarithm is α, i.e.,
lim
n→∞ c(n) = b(n) ≡
n
logα(n)
(3)
For a 0-1 sequence, α = 2, therefore
b(n) ≡ n
log2(n)
(4)
and c(n) can be normalized via b(n):
C(n) =
c(n)
b(n)
(5)
C(n), the normalized LZ complexity, reflects the arising
rate of new patterns along with the sequence. Thus, it
captures the temporal structure of the sequence.
D. Statistical analysis
The analyses were carried out separately for each channel.
In order to determine if there are any differences between
the LZ complexity values in both groups, control subjects
and AD patients, a Student t-test was used.
III. RESULTS
We have used the LZ complexity to quantify the complex-
ity in the time-series data. The epoch length was fixed at 3392
samples and we have coded the series about the median by
a binary sequence (0-1) in the calculation of LZ complexity.
Fig. 1 resumes the average LZ complexity values estimated
for the patients with AD and the control subjects, for the
MEG channels (A1-A148). This average value is higher in
the control group’s MEG for all channels. Mean values were
0.78± 0.06 in the control group and 0.69± 0.08 in the AD
patients group.
The LZ complexity values suggest that the complexity (in
the sense of number of new subsequences in the data) in
AD patients’ MEGs is lower. This difference is statistically
significant when using a Student t-test in 77 channels (p <
0.01), as can be seen in Fig. 2. Fourteen of these channels
(dark grey colored) have a p < 0.001 (A16, A17, A32, A33,
A34, A51, A52, A53, A69, A73, A74, A75, A93 and A112).
These results suggest that MEG activity of AD patients is
less complex in certain regions than in a normal brain.
IV. DISCUSSION AND CONCLUSION
MEG is a non-invasive neurophysiological technique that
allows measuring the magnetic fields generated by brain
activity, with millisecond temporal resolution and spatial res-
olution exceeding that of conventional EEG [26]. Although
it was firstly used more than 30 years ago, MEG is still
widely considered a new neurophysiological technique. To
our knowledge the present study is the first that has used
the LZ complexity to study multichannel MEG data in AD
patients.
LZ complexity is an easy and fast method to measure
the time series complexity. Only two simple mathematical
operations are needed for the calculation of the LZ complex-
ity: sequence comparison and number accumulation. It is a
coarse-graining measure because the MEG data are trans-
formed into a pattern whose elements are only two symbols
(0-1). Although other conversions with more symbols could
keep more information, previous studies have demonstrated
that a binary conversion is enough to study the complexity
of a system [22]. Moreover, the median value is robust to
outliers. These advantages support the proposal that the LZ
complexity is a good measure of the complexity of biological
signals as the MEG.
In this research AD patients group and control group were
carefully matched for age (AD patients, mean age ± SD 66.3
± 7.1 years; control subjects, mean age ± SD 65.8 ± 5.9
years). Therefore, the complexity loss may well represent
the cognitive dysfunction in AD. It is remarkable that the
accuracy in the clinical diagnosis of AD is less than 90%.
So, it is possible that not all the patients have AD.
In summary, our results suggest that the LZ complexity is
a good method to differentiate between the two groups we
Fig. 1. The average LZ complexity values of the MEGs in Alzheimer disease patients and control subjects for all channels, from A1 to A148.
Fig. 2. Squids diagram with p values.
have studied. Nevertheless, more AD patients and control
subjects’ recordings are needed to confirm the preliminary
results obtained in this research.
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